Citations are updated once a week. Recently added citations may not appear.
Context | Citation |
---|---|
Bismuth Salts |
?
Antimicrobial activity of bismuth subsalicylate on Clostridium difficile, Escherichia coli O157:H7, norovirus, and other common enteric pathogens. Gut microbes (Gut Microbes ) Vol: 6 Issue 2 Pages: 93-100 Pub: 2015 Epub: Authors Pitz AM , Park GW , Lee D , Boissy YL , Vinjé J , Html Article Publication |
Bismuth Salts |
?
Toxicity of Methylated Bismuth Compounds Produced by Intestinal Microorganisms to Bacteroides thetaiotaomicron, a Member of the Physiological Intestinal Microbiota. Journal of toxicology (J Toxicol ) Vol: 2011 Issue Pages: 608349 Pub: 2011 Epub: 2011 Sep 28 Authors Bialek B , Diaz-Bone RA , Pieper D , Hollmann M , Hensel R , Html Article Publication |
Bismuth Salts |
?
Estimating modifiers from bacteria associations Microbiome Prescription (Lassesen Consulting, LLC ) Vol: 2023 Issue 3 Pages: 3342-3347 Pub: 2023 Apr Epub: Authors K Lassesen , Publication |
Bismuth Salts |
?
In vitro antimicrobial activity of bismuth subsalicylate and other bismuth salts. Reviews of infectious diseases (Rev Infect Dis ) Vol: 12 Suppl 1 Issue Pages: S11-5 Pub: 1990 Jan-Feb Epub: Authors Manhart MD , Publication |
Bismuth Salts |
?
Helicobacter pylori eradication with bismuth quadruple therapy leads to dysbiosis of gut microbiota with an increased relative abundance of Proteobacteria and decreased relative abundances of Bacteroidetes and Actinobacteria. Helicobacter (Helicobacter ) Vol: Issue Pages: e12498 Pub: 2018 Jun 13 Epub: 2018 Jun 13 Authors Hsu PI , Pan CY , Kao JY , Tsay FW , Peng NJ , Kao SS , Wang HM , Tsai TJ , Wu DC , Chen CL , Tsai KW , Taiwan Acid-related Disease (TARD) Study Group. , Publication |
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.